The gut microbiota plays a key role in cholesterol metabolism, mainly through the reduction of cholesterol to coprostanol. The latter sterol exhibits distinct physicochemical properties linked to its limited absorption in the gut. Few bacteria were reported to reduce cholesterol into coprostanol. Three microbial pathways of coprostanol production were described based on the analysis of reaction intermediates. However, these metabolic pathways and their associated genes remain poorly studied. In this review, we shed light on the microbial metabolic pathways related to coprostanol synthesis. Moreover, we highlight current strategies and future directions to better characterize these microbial enzymes and pathways
Bifidobacteria are members of the human gut microbiota, which are known to influence the metabolic a...
seudoalteromonas haloplanktis, a psychrotrophilic marine bacterium of biotechnological interest, sho...
Cholesterol (CH) level management is a keystone to limit cardiovascular diseases. The contrasted eff...
The gut microbiota plays a key role in cholesterol metabolism, mainly through the reduction of chole...
Every day, up to 1 g of cholesterol, composed of the unabsorbed dietary cholesterol, the biliary cho...
The human microbiome encodes extensive metabolic capabilities, but our understanding of the mechanis...
The human gastro-intestinal tract hosts a complex and diverse microbial community, whose collective ...
The human gastro-intestinal tract hosts a complex and diverse microbial community, whose collective ...
The efficiency of microbial reduction of cholesterol to coprostanol in human gut is highly variable ...
La réduction du taux de cholestérol (CH) sanguin est un point clé dans la lutte contre les maladies ...
Cholesterol reductase was discovered in certain green plant parts. The enzyme is known to be present...
The microbial community in the human colon contains bacteria that reduce cholesterol to coprostanol,...
The human gastro-intestinal tract hosts a complex and diverse microbial community, whose microbiome ...
Bifidobacteria are members of the human gut microbiota, which are known to influence the metabolic a...
A novel cholesterol-reducing bacterium, Eubacterium coprostanoligenes ATCC 51222, was characterized ...
Bifidobacteria are members of the human gut microbiota, which are known to influence the metabolic a...
seudoalteromonas haloplanktis, a psychrotrophilic marine bacterium of biotechnological interest, sho...
Cholesterol (CH) level management is a keystone to limit cardiovascular diseases. The contrasted eff...
The gut microbiota plays a key role in cholesterol metabolism, mainly through the reduction of chole...
Every day, up to 1 g of cholesterol, composed of the unabsorbed dietary cholesterol, the biliary cho...
The human microbiome encodes extensive metabolic capabilities, but our understanding of the mechanis...
The human gastro-intestinal tract hosts a complex and diverse microbial community, whose collective ...
The human gastro-intestinal tract hosts a complex and diverse microbial community, whose collective ...
The efficiency of microbial reduction of cholesterol to coprostanol in human gut is highly variable ...
La réduction du taux de cholestérol (CH) sanguin est un point clé dans la lutte contre les maladies ...
Cholesterol reductase was discovered in certain green plant parts. The enzyme is known to be present...
The microbial community in the human colon contains bacteria that reduce cholesterol to coprostanol,...
The human gastro-intestinal tract hosts a complex and diverse microbial community, whose microbiome ...
Bifidobacteria are members of the human gut microbiota, which are known to influence the metabolic a...
A novel cholesterol-reducing bacterium, Eubacterium coprostanoligenes ATCC 51222, was characterized ...
Bifidobacteria are members of the human gut microbiota, which are known to influence the metabolic a...
seudoalteromonas haloplanktis, a psychrotrophilic marine bacterium of biotechnological interest, sho...
Cholesterol (CH) level management is a keystone to limit cardiovascular diseases. The contrasted eff...